The same results demonstrated that protein expression of IL-17, IL-6, IL-1β, and TNF-α is significantly upregulated by DM treatment, while siMIAT treatment downregulates its protein expression, well corresponding to what we observed in vitro (Figures 6C,J,K). This evidence concerns the gene IL17A and diabetes mellitus.